Abbott Gains FDA Authorization for Dual Glucose-Ketone Sensor
ABBOTT PARK, Ill., August 25, 2026 Abbott announced that the U.S. Food and Drug Administration (FDA) has authorized Libre...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ABBOTT PARK, Ill., August 25, 2026 Abbott announced that the U.S. Food and Drug Administration (FDA) has authorized Libre...
New York, New York, August 20, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...
Silver Spring, Maryland, August 19, 2026 The U.S. Food and Drug Administration (FDA) has authorized Aletta, a first-of-its-kind standalone...
IRVINE, California, USA – June 8, 2026 Thirdwayv Inc. has highlighted the role of its advanced age-gating and authentication...
VANCOUVER, British Columbia, May 29, 2026 Optimi Health Corp. has welcomed new recommendations issued by Australia’s Therapeutic Goods Administration...
MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...
CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
